唐氏综合征合并轻度阻塞性睡眠呼吸暂停患儿的非手术治疗结局
结果显示各组治疗后oAHI、血氧饱和度最低值、ETCO2及REM睡眠比例均无显著变化,OSA缓解率低(药物20%、观察7.7%、氧疗0%),提示应考虑多模式治疗。
要点
- 唐氏综合征合并轻度OSA患儿非手术治疗后多导睡眠图指标无显著改善。
- 单药治疗、氧疗或观察的OSA缓解率均较低,组间无显著差异。
- 建议对此类患儿考虑多模式联合治疗而非单一非手术干预。
核心结论
- 在唐氏综合征合并轻度OSA患儿中,非手术治疗(药物、氧疗或观察)后OSA缓解率低,多导睡眠图指标无显著改善。
主要发现
- 各组基线oAHI分别为药物治疗组3.5次/小时、氧疗组3.3次/小时、观察组2.9次/小时。
- 报告症状与AHI严重程度或AHI变化无关联。
- OSA加重:药物治疗组和观察组各2例。
关键数值与推荐
- 轻度OSA定义为阻塞性呼吸暂停低通气指数(oAHI)≥1且<5次/小时。
临床怎么用
- 对于唐氏综合征合并轻度OSA的患儿,单一非手术治疗(药物、氧疗或观察)效果有限,应考虑多模式联合治疗。
- 需开展前瞻性研究以明确该人群的有效治疗策略。
局限性
- 各组样本量不均(药物10例、氧疗1例、观察13例),氧疗组仅1例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Nasal steroids, oral anti-leukotrienes and supplemental oxygen are effective in the treatment of mild obstructive sleep apnea (OSA) in otherwise healthy children. However, their efficacy is unknown in children with Down syndrome (DS). Here we examine the effect of single medication therapy versus observation versus oxygen on polysomnographic outcomes in these children. METHODS: We reviewed children (<18 years) diagnosed with DS and mild OSA (obstructive apnea-hypopnea index [oAHI] ≥1 to <5 events/hour) treated non-surgically (with supplemental oxygen, one medication, or observation) between 2012 and 2017. Demographic data, comorbid diagnoses, and pre- and posttreatment polysomnograms were analyzed. We assessed pre- and posttreatment oAHI, oxyhemoglobin saturation nadir, percent total sleep time (%TST) in rapid eye movement (REM), and end-tidal carbon dioxide (ETCO2 ) >50 mmHg. RESULTS: Twenty-four children met inclusion criteria; 10 treated with medication, one with oxygen, and 13 with observation (baseline oAHI was 3.5, 3.3, and 2.9 events/hour, respectively). There was no significant change in oAHI, oxyhemoglobin saturation nadir, ETCO2 , or percent TST in REM after treatment for any treatment group (P = .21-.94). There was no association between reported symptoms and AHI severity or change in AHI. OSA resolved in one patient treated with observation and two treated with medication, but worsened in two each in the medication and observation groups. Resolution of OSA occurred in 20% treated with medication, 7.7% with observation, and 0% with oxygen (P = .82). CONCLUSION: In our cohort, resolution of mild OSA was low. This suggests that consideration should be given to multimodality treatments in children with DS and mild OSA. Prospective studies will help establish effectiveness in this cohort. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:1828-1835, 2020.
引用
- Howard JJM, Sarber KM, Yu W, et al. Outcomes in children with down syndrome and mild obstructive sleep apnea treated non-surgically. Laryngoscope. 2019. PMID: 31603543. doi:10.1002/lary.28325
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。